Ipca Laboratories Ltd

  • BSE Code : 524494
  • NSE Symbol : IPCALAB
  • ISIN : INE571A01038
  • Industry :PHARMACEUTICALS - INDIAN - BULK DRUGS & FORMLN

up-arrow 1,310.30 -4.50(-0.34%)

Open Price ()

1,319.00

Prev. Close ()

1,314.80

Volume (No’s)

108,722

Market Cap ()

33,242.86

Low Price ()

1,301.70

High Price ()

1,321.90

 

Board Meetings

Start Date End Date Purpose
24-Jul-2025 11-Aug-2025 Ipca Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2025 inter alia to consider and approve Standalone and Consolidated Results for Q1FY26 Standalone and Consolidated Unaudited Financial Results Financial Results (As per BSE Announcement Dated on 11.08.2025)
14-May-2025 29-May-2025 Ipca Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2025 inter alia to consider and approve Standalone & Consolidated Audited Financial Results for the 4th Quarter and FY25 and recommendation of final dividend for FY 24-25 Board Meeting Outcome for Standalone And Consolidated Audited Financial Results For Q4FY25 Standalone and Consolidated Audited Financial Results for Q4FY25 Amendment to Memorandum of Association (As Per BSE Announcement Dated on: 29/05/2025)
28-Mar-2025 28-Mar-2025 Outcome of Board Meeting - 28.03.2025
27-Jan-2025 13-Feb-2025 IPCA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2025 inter alia to consider and approve Standalone and Consolidated Unaudited Financial Results for Q3 and nine months ended 31st December 2024 Standalone and Consolidated Q3FY25 Results & Press Release (As Per BSE Announcement Dated on: 13/02/2025)
24-Oct-2024 14-Nov-2024 IPCA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2024 inter alia to consider and approve Standalone and Consolidated Financial Results for 2nd quarter and half year ended 30th September 2024 and Declaration of Interim Dividend Board declares Interim Dividend of Rs. 2/- per share of Re. 1/- each (200%) (As per BSE Announcement Dated on 14/11/2024)

Copyright © 2024 Arihant Capital Markets Ltd. All rights Reserved.

Designed,Developed and Content powered by CMOTS Infotech (ISO 9001:2015 certified)

x
  • QR-CodeNew